ClinicalTrials.Veeva

Menu

A Long-term Follow-up Study of Pulmonary Function Changes Using Phase-resolved Functional Lung MRI in Patients With COVID-19

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Pulmonary Function

Treatments

Diagnostic Test: Functional lung MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05933317
202212301

Details and patient eligibility

About

So far, the number of COVID-19 infections worldwide has exceeded 700 million. Long-term damage to the lungs is a major sequela of COVID infection. Pulmonary function testing is an important means for the evaluation of lung damage. MRI examinations with free breathing and no contrast agent can prevent patients from suffering from ionizing radiation damage caused by multiple CT examinations.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Older than 18 years; Sign the informed consent; Patients diagnosed with COVID-19 by nucleic acid test and survived to be discharged; Complete clinical data during hospitalization.

Exclusion criteria

  • Patients with bacterial pneumonia; Patients with MRI contraindications.

Trial contacts and locations

1

Loading...

Central trial contact

Tao Ouyang, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems